HK1199879A1 - Pde9 inhibitors with imidazo triazinone backbone pde9 - Google Patents

Pde9 inhibitors with imidazo triazinone backbone pde9

Info

Publication number
HK1199879A1
HK1199879A1 HK15100346.4A HK15100346A HK1199879A1 HK 1199879 A1 HK1199879 A1 HK 1199879A1 HK 15100346 A HK15100346 A HK 15100346A HK 1199879 A1 HK1199879 A1 HK 1199879A1
Authority
HK
Hong Kong
Prior art keywords
pde9
inhibitors
backbone
imidazo
imidazo triazinone
Prior art date
Application number
HK15100346.4A
Other languages
English (en)
Chinese (zh)
Inventor
Niels Svenstrup
Klaus Baek Simonsen
Lars Kyhn Rasmussen
Karsten Juhl
Morten Langgard
Kate Wen
Yazhou Wang
Original Assignee
Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck As filed Critical Lundbeck As
Publication of HK1199879A1 publication Critical patent/HK1199879A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK15100346.4A 2012-01-26 2015-01-13 Pde9 inhibitors with imidazo triazinone backbone pde9 HK1199879A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2012070718 2012-01-26
CN2012080208 2012-08-16
PCT/EP2013/051451 WO2013110768A1 (fr) 2012-01-26 2013-01-25 Inhibiteurs de pde9 comprenant un squelette imidazotriazinone

Publications (1)

Publication Number Publication Date
HK1199879A1 true HK1199879A1 (en) 2015-07-24

Family

ID=47603775

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15100346.4A HK1199879A1 (en) 2012-01-26 2015-01-13 Pde9 inhibitors with imidazo triazinone backbone pde9

Country Status (15)

Country Link
US (3) US9434733B2 (fr)
EP (2) EP2807163B1 (fr)
CN (2) CN104093720B (fr)
AP (1) AP2014007820A0 (fr)
AU (2) AU2013213603B2 (fr)
BR (1) BR112014018199A8 (fr)
CO (1) CO7020913A2 (fr)
CR (1) CR20140361A (fr)
DO (1) DOP2014000175A (fr)
EC (1) ECSP14015609A (fr)
HK (1) HK1199879A1 (fr)
MX (1) MX351582B (fr)
PH (1) PH12014501695B1 (fr)
SG (1) SG11201403909RA (fr)
WO (1) WO2013110768A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR083058A1 (es) 2010-09-20 2013-01-30 Envivo Pharmaceuticals Inc Compuestos de estructura de imidazotriazinona
WO2012047121A1 (fr) 2010-10-08 2012-04-12 Fisher & Paykel Healthcare Limited Appareil d'assistance respiratoire
EP2906562B1 (fr) 2011-10-10 2016-10-05 H. Lundbeck A/S Pde9i ayant un squelette imidazo pyrazinone
CN104093720B (zh) * 2012-01-26 2017-04-12 H.隆德贝克有限公司 具有咪唑并三嗪酮骨架的pde9抑制剂
EP2828262A4 (fr) * 2012-03-19 2015-09-23 Forum Pharmaceuticals Inc Composés d'imidazotriazinone
KR20160007347A (ko) 2014-07-11 2016-01-20 에스티팜 주식회사 신규한 이미다조트리아지논 또는 이미다조피라지논 유도체, 및 이들의 용도
WO2016006975A2 (fr) * 2014-07-11 2016-01-14 St Pharm Co., Ltd. Nouveaux dérivés imidazotriazinone ou imidazopyrazinone et leur utilisation
TW201629064A (zh) 2014-10-10 2016-08-16 Ｈ 朗德貝克公司 作爲ｐｄｅ１抑制劑之三唑並吡酮
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
WO2017000276A1 (fr) 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Composés hétérocycliques bicycliques utilisés en tant qu'inhibiteurs de pde2
SI3865484T1 (sl) 2015-07-07 2024-05-31 H. Lundbeck A/S Zaviralec pde9 z imidazo pirazinonsko hrbtenico za zdravljenje perifernih bolezni
CN105669680B (zh) * 2016-03-24 2018-02-23 南京药捷安康生物科技有限公司 吡咯并[2,1‑f][1,2,4]三嗪‑4(1H)‑酮衍生物类PDE9A抑制剂
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商Ｈ 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
BR112019000005A2 (pt) * 2016-07-06 2019-04-16 H. Lundbeck A/S inibidores de pde9 para o tratamento de doenças periféricas
EP3529250B1 (fr) 2016-10-18 2023-12-06 H. Lundbeck A/S Imidazopyrazinones, pyrazolopyrimidinones et pyrazolopyridinones en tant qu'inhibiteurs de pde1
MA46611B1 (fr) 2016-10-28 2020-08-31 H Lundbeck As Traitements combinés comprenant des imidazopyrazinones pour le traitement de troubles psychiatriques et/ou cognitifs
CA3041595A1 (fr) 2016-10-28 2018-05-03 H. Lundbeck A/S Traitements combines comprenant l'administration d'imidazopyrazinones
PT3541784T (pt) * 2016-11-18 2023-11-22 Integrative Res Laboratories Sweden Ab Novos derivados de azetidina úteis como moduladores da neurotransmissão catecolaminérgica cortical
KR102643197B1 (ko) * 2017-02-23 2024-03-06 베링거 인겔하임 인터내셔날 게엠베하 화합물 iii의 새로운 의학 용도
TWI843393B (zh) 2017-05-26 2024-05-21 美商卡杜隆製藥公司 製備和使用ｐｄｅ９抑制劑之方法
CN110003213B (zh) * 2018-01-04 2021-10-08 南京农业大学 苯并咪唑并三嗪酮类化合物、制备方法及应用
MX2020007066A (es) 2018-01-05 2020-09-09 Dicerna Pharmaceuticals Inc Reduccion de la expresion de beta-catenina e ido para potenciar la inmunoterapia.
BR112020024019A2 (pt) 2018-05-25 2021-02-23 Imara Inc. monoidrato e formas cristalinas de 6-[(3s,4s)-4-metil-1-(pirimidin-2-ilmetil)pirrolidin-3-il]-3-tetra-hidropiran-4-il-7h-imidazo[1,5-a]pirazin-8-ona
EP3965768A1 (fr) * 2019-05-07 2022-03-16 Imara Inc. Inhibiteurs de pde9 pour le traitement de la thalassémie
CN113072556B (zh) * 2021-03-30 2022-02-01 牡丹江医学院 一种用于治疗胶质瘤的药物及其制备方法
WO2024107445A1 (fr) * 2022-11-15 2024-05-23 Freedom Biosciences, Inc. Amélioration de l'efficacité de médicaments psychédéliques sérotoninergiques dans le traitement ou la prévention de certains troubles neuropsychiatriques par inhibition de phosphodiestérases de type-9

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23063A3 (es) 1997-11-12 2005-07-19 Bayer Ag Imidazotriazinonas 2-fenil sustituidas como inhibidores de fosfodiesterasas
SK10322001A3 (sk) 1999-01-20 2002-07-02 Arzneimittelwerk Dresden Gmbh Spôsob prípravy imidazo [1,5-a]pyrido[3,2-e]pyrazínov, farmaceutické prostriedky obsahujúce takéto zlúčeniny a spôsob výroby farmaceutického prostriedku
KR20040053210A (ko) * 2001-11-02 2004-06-23 화이자 프로덕츠 인크. Ｐｄｅ9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
HN2002000317A (es) 2001-11-02 2003-05-21 Pfizer Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
GB2388111A (en) 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
US6684626B1 (en) 2002-07-30 2004-02-03 General Electric Company Aircraft gas turbine engine with control vanes for counter rotating low pressure turbines
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
BRPI0416118A (pt) 2003-10-31 2007-01-02 Pfizer Prod Inc inibição da fosfodiesterase 9 como tratamento para estados relacionados com a obesidade
AR053090A1 (es) 2004-07-20 2007-04-25 Osi Pharm Inc Imidazotriazinas como inhibidores de proteina quinasas y su uso para la preparacion de medicamentos
TW200815436A (en) 2006-05-30 2008-04-01 Elbion Ag 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
US8299080B2 (en) 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
RS52166B (en) * 2007-05-11 2012-08-31 Pfizer Inc. AMINO-HETEROCYCLIC COMPOUNDS
DE102007032349A1 (de) 2007-07-11 2009-01-15 Bayer Healthcare Ag Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung
EA201070725A1 (ru) 2007-12-10 2011-02-28 Глэксо Груп Лимитед Бис-пиридилпиридоны как антагонисты рецептора 1 меланинконцентрирующего гормона
TWI404721B (zh) 2009-01-26 2013-08-11 Pfizer 胺基－雜環化合物
US20110082147A1 (en) 2009-07-24 2011-04-07 Concert Pharmaceuticals, Inc. Substituted imidazotriazines
US9260432B2 (en) 2009-09-02 2016-02-16 Concert Pharmaceuticals, Inc. Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
AR083058A1 (es) * 2010-09-20 2013-01-30 Envivo Pharmaceuticals Inc Compuestos de estructura de imidazotriazinona
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
CN104093720B (zh) 2012-01-26 2017-04-12 H.隆德贝克有限公司 具有咪唑并三嗪酮骨架的pde9抑制剂

Also Published As

Publication number Publication date
CR20140361A (es) 2014-11-11
DOP2014000175A (es) 2014-08-31
EP3178820A1 (fr) 2017-06-14
AU2017200886A1 (en) 2017-03-02
CN107082783B (zh) 2019-03-22
AU2017200886B2 (en) 2018-01-18
SG11201403909RA (en) 2014-10-30
AP2014007820A0 (en) 2014-07-31
PH12014501695A1 (en) 2014-10-20
WO2013110768A1 (fr) 2013-08-01
US9434733B2 (en) 2016-09-06
US9533992B2 (en) 2017-01-03
CO7020913A2 (es) 2014-08-11
US9850249B2 (en) 2017-12-26
MX351582B (es) 2017-10-20
CN104093720B (zh) 2017-04-12
CN107082783A (zh) 2017-08-22
US20150045348A1 (en) 2015-02-12
EP3178820B1 (fr) 2017-12-20
EP2807163A1 (fr) 2014-12-03
US20170081333A1 (en) 2017-03-23
AU2013213603A1 (en) 2014-07-24
ECSP14015609A (es) 2015-12-31
MX2014008912A (es) 2014-08-26
EP2807163B1 (fr) 2017-03-22
PH12014501695B1 (en) 2014-10-20
US20160213674A1 (en) 2016-07-28
BR112014018199A8 (pt) 2021-03-02
CN104093720A (zh) 2014-10-08
AU2013213603B2 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
HK1199879A1 (en) Pde9 inhibitors with imidazo triazinone backbone pde9
IL253448A0 (en) Pde91 is an imidazo- pyrazinone backbone
HRP20181041T1 (hr) Pirazolopirimidinski spojevi
HK1208444A1 (en) Pyrrolobenzodiazepines
HK1208217A1 (en) Pyrrolobenzodiazepines
HK1206795A1 (en) Rapid aneuploidy detection
EP2865097A4 (fr) Récepteur à haute efficacité spectrale
HK1211029A1 (en) Pyrazolopyrimidine compounds
EP2934535A4 (fr) Pyrrolopyrimidines substituées en tant qu'inhibiteurs de hdm2
IL230997A0 (en) 10pde pyrimidine inhibitors
EP2785183A4 (fr) Inhibiteurs de pde10 de triazolopyridinone
GB2499421B (en) Ramp
IL235829A0 (en) Triazolo compounds as pde10 inhibitors
EP2621926A4 (fr) Inhibiteurs de pyrazolopyrimidine pde10
GB201215033D0 (en) Diazepinone derivatives
GB201219935D0 (en) Belt it
EP2922823A4 (fr) Inhibiteurs pyrimidines de pde10
HK1204617A1 (en) Triazolo compounds as pde10 inhibitors pde10
EP2919783A4 (fr) Cyclopropylimidazopyridine utilisable en tant qu'inhibiteur de pde10
GB201218984D0 (en) Receiver
GB201214593D0 (en) Spirit level clamp
HU4129U (en) Multi-purpose lighting device
AU2012104V (en) Proquest M703 Mandevilla hybrid
GB201204319D0 (en) Floor insert